C-reactive protein as a prognostic tool in cardiovascular practices: should CRP testing be ordered along with lipid...

Area of Science:

• Cardiovascular Medicine
• Clinical Chemistry
• Biomarker Research

Background:

• C-reactive protein (CRP) is an inflammatory marker.
• Cardiovascular disease (CVD) risk assessment relies on established factors.
• The role of CRP in refining CVD risk prediction is under investigation.

Purpose of the Study:

• To evaluate the association between CRP levels and clinical cardiovascular events.
• To determine the clinical utility of CRP testing in cardiovascular risk stratification.
• To assess the added predictive value of CRP beyond traditional risk factors.

Main Methods:

• Analysis of the dose-response relationship between CRP and cardiovascular events.
• Examination of CRP's predictive value after adjusting for other risk factors.
• Evaluation of CRP's utility in specific patient risk groups (10-20% 10-year risk).

Main Results:

• A graded, dose-response relationship exists between CRP and cardiovascular events (RR≈2).
• CRP may improve risk estimation for patients with a 10-year risk between 10-20%.
• CRP testing is unlikely to identify high risk in individuals already at low risk (<10%).

Conclusions:

• CRP demonstrates a significant association with cardiovascular events, independent of other risk factors.
• CRP testing may offer clinical utility for intermediate-risk individuals but not for low-risk patients.
• Further research is needed to confirm CRP's added predictive value; routine co-ordering with lipid profiles is not currently recommended.